Evidence Suggesting That Alzheimer's Disease May Be a Transmissible Disorder

被引:0
作者
Saw, Genevieve [1 ]
Yi, Ling-Xiao [1 ]
Tan, Eng King [1 ,2 ,3 ]
Zhou, Zhi Dong [1 ,3 ]
机构
[1] Natl Neurosci Inst, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
[2] Singapore Gen Hosp, Dept Neurol, Outram Rd, Singapore 169608, Singapore
[3] Duke NUS Med Sch, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore
基金
英国医学研究理事会;
关键词
Alzheimer's disease; transmissible disease; protein aggregation; neurodegeneration; pathogenesis; therapeutic strategies; CREUTZFELDT-JAKOB-DISEASE; DURA-MATER; BETA DEPOSITION; PATHOLOGY; ACCUMULATION; TAUOPATHY; TAU;
D O I
10.3390/ijms26020508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is characterised by progressive neurodegeneration with the formation of amyloid beta (A beta) plaques and neurofibrillary tau tangles in the brain parenchyma. The causes of AD have been attributed to a combination of age-related changes within the brain as well as genetic, environmental and lifestyle factors. However, a recent study by Banerjee et al. highlights the possibility that AD may be a transmissible disease and that iatrogenic AD could be environmentally acquired, similar to iatrogenic Creutzfeldt-Jakob disease (iCJD). The study reports that contaminated A beta in cadaver-derived pituitary growth hormone (c-hGH) therapy, which patients received during childhood inoculation, may accidentally transmit into their brains, triggering neurodegeneration and AD onset in older age. Furthermore, corroborating evidence from various animal model studies and human case reports suggests that AD can be potentially transmissible.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease
    Xiong, Yong-lan
    Meng, Tao
    Luo, Jing
    Zhang, Hua
    EUROPEAN NEUROLOGY, 2021, 84 (01) : 6 - 15
  • [42] Gut microbial involvement in Alzheimer's disease pathogenesis
    Zhang, Yu
    Geng, Rulin
    Tu, Qiuyun
    AGING-US, 2021, 13 (09): : 13359 - 13371
  • [43] Implication of tau propagation on neurodegeneration in Alzheimer's disease
    Lamontagne-Kam, Daniel
    Ulfat, Anosha Kiran
    Herve, Vincent
    Vu, Tra-My
    Brouillette, Jonathan
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [44] Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease
    Katy A. Chalmers
    Gordon K. Wilcock
    Harry V. Vinters
    Elaine K. Perry
    Robert Perry
    Clive G. Ballard
    Seth Love
    Journal of Neurology, 2009, 256 : 717 - 720
  • [45] Gut microbiome composition may be an indicator of preclinical Alzheimer's disease
    Ferreiro, Aura L.
    Choi, JooHee
    Ryou, Jian
    Newcomer, Erin P.
    Thompson, Regina
    Bollinger, Rebecca M.
    Hall-Moore, Carla
    Ndao, I. Malick
    Sax, Laurie
    Benzinger, Tammie L. S.
    Stark, Susan L.
    Holtzman, David M.
    Fagan, Anne M.
    Schindler, Suzanne E.
    Cruchaga, Carlos
    Butt, Omar H.
    Morris, John C.
    Tarr, Phillip I.
    Ances, Beau M.
    Dantas, Gautam
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (700)
  • [46] Psychotherapies for neurocognitive disorder due to alzheimer's disease- the current level of evidence
    Vasile, D.
    Vasiliu, O.
    Vasiliu, D.
    EUROPEAN PSYCHIATRY, 2021, 64 : S420 - S420
  • [47] SUMO and Alzheimer's Disease
    Lee, Linda
    Sakurai, Mikako
    Matsuzaki, Shinsuke
    Arancio, Ottavio
    Fraser, Paul
    NEUROMOLECULAR MEDICINE, 2013, 15 (04) : 720 - 736
  • [48] SUMO and Alzheimer’s Disease
    Linda Lee
    Mikako Sakurai
    Shinsuke Matsuzaki
    Ottavio Arancio
    Paul Fraser
    NeuroMolecular Medicine, 2013, 15 : 720 - 736
  • [49] Modeling the complex pathology of Alzheimer's disease in Drosophila
    Fernandez-Funez, Pedro
    de Mena, Lorena
    Rincon-Limas, Diego E.
    EXPERIMENTAL NEUROLOGY, 2015, 274 : 58 - 71
  • [50] The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
    Cummings, Jeffrey
    ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 172 - 178